Literature DB >> 22634148

Role of mtDNA haplogroups in COPD susceptibility in a southwestern Han Chinese population.

Shizhen Zheng1, Changzheng Wang, Guisheng Qian, Guoming Wu, Ruiling Guo, Qi Li, Yan Chen, Jin Li, Haining Li, Binfeng He, Huaping Chen, Fuyun Ji.   

Abstract

The interplay of a complex genetic basis with the environmental factors of chronic obstructive pulmonary disease (COPD) may account for the differences in individual susceptibility to COPD. Mitochondrial DNA (mtDNA) contributes to an individual's ability to resist oxidation, an important determinant that affects COPD susceptibility. To investigate whether mtDNA haplogroups play important roles in COPD susceptibility, the frequencies of mtDNA haplogroups and an 822-bp mtDNA deletion in 671 COPD patients and 724 control individuals from southwestern China were compared. Multivariate logistic regression analysis revealed that, whereas mtDNA haplogroups A and M7 might be associated with an increased risk for COPD (OR=1.996, 95% CI=1.149-2.831, p=0.006, and OR=1.754, 95% CI=1.931-2.552, p=0.021, respectively), haplogroups F, D, and M9 might be associated with a decreased risk for COPD in this population (OR=0.554, 95% CI=0.390-0.787, p=0.001; OR=0.758, 95% CI=0.407-0.965, p=0.002; and OR=0.186, 95% CI=0.039-0.881, p=0.034, respectively). Additionally, the increased frequency of the 822-bp mtDNA deletion in male cigarette-smoking subjects among COPD patients and controls of haplogroup D indicated that haplogroup D might increase an individual's susceptibility to DNA damage from external reactive oxygen species derived from heavy cigarette smoking. We conclude that haplogroups A and M7 might be risk factors for COPD, whereas haplogroups D, F, and M9 might decrease the COPD risk in this Han Chinese population.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22634148     DOI: 10.1016/j.freeradbiomed.2012.05.019

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  6 in total

Review 1.  Mitochondria in lung disease.

Authors:  Suzanne M Cloonan; Augustine M K Choi
Journal:  J Clin Invest       Date:  2016-03-01       Impact factor: 14.808

Review 2.  Cellular Senescence in Aging Lungs and Diseases.

Authors:  Arbi Aghali; Maunick Lefin Koloko Ngassie; Christina M Pabelick; Y S Prakash
Journal:  Cells       Date:  2022-05-29       Impact factor: 7.666

3.  Do sputum or circulating blood samples reflect the pulmonary transcriptomic differences of COPD patients? A multi-tissue transcriptomic network META-analysis.

Authors:  Rosa Faner; Jarrett D Morrow; Sandra Casas-Recasens; Suzanne M Cloonan; Guillaume Noell; Alejandra López-Giraldo; Ruth Tal-Singer; Bruce E Miller; Edwin K Silverman; Alvar Agustí; Craig P Hersh
Journal:  Respir Res       Date:  2019-01-08

4.  Mitochondrial DNA Haplogroup M7 Confers Disability in a Chinese Aging Population.

Authors:  Dayan Sun; Shun Yao; Fei Wu; Wan Deng; Yanyun Ma; Li Jin; Jiucun Wang; Xiaofeng Wang
Journal:  Front Genet       Date:  2020-10-23       Impact factor: 4.599

5.  Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID-19 in a Han Chinese population from Central China.

Authors:  Yi Wu; Xian-Hui Wang; Xi-Hua Li; Li-Yuan Song; Shi-Long Yu; Zhi-Cheng Fang; Yu-Quan Liu; Le-Yong Yuan; Chun-Yan Peng; Shen-Yi Zhang; Wang Cheng; Hong-Chao Ma; Li-Feng Wang; Jun-Ming Tang; Yun-Fu Wang; Fu-Yun Ji
Journal:  Mil Med Res       Date:  2021-11-01

Review 6.  Mitochondrial genetic medicine.

Authors:  Douglas C Wallace
Journal:  Nat Genet       Date:  2018-10-29       Impact factor: 38.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.